Cargando…
Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis
BACKGROUND: Currently, 6-month oxaliplatin-based chemotherapy has been recommended as the preferred adjuvant treatment against high-risk stage 2 and stage 3 colon cancer patients. METHODS: Record retrieval was conducted in PubMed, Web of Science, Cochrane Central Register of Controlled Trials, Ameri...
Autores principales: | Cheng, Ji, Shuai, Xiaoming, Gao, Jinbo, Wang, Guobin, Tao, Kaixiong, Cai, Kailin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739130/ https://www.ncbi.nlm.nih.gov/pubmed/33403014 http://dx.doi.org/10.1177/1758835920974195 |
Ejemplares similares
-
Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019) -
Two-dimensional versus three-dimensional laparoscopy in surgical efficacy: a systematic review and meta-analysis
por: Cheng, Ji, et al.
Publicado: (2016) -
Prognostic significance of AMPK in human malignancies: A meta-analysis
por: Cheng, Ji, et al.
Publicado: (2016) -
The Safety and Efficiency of Surgery with Colonic Stents in Left-Sided Malignant Colonic Obstruction: A Meta-Analysis
por: Zhao, Xiang, et al.
Publicado: (2014) -
First-line systemic therapy for advanced gastric cancer: a systematic
review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019)